Seeing Is Believing

Currently out of the existing stock ratings of Ahu Demir, 2 are a HOLD (12.5%), 14 are a BUY (87.5%).
Analyst Ahu Demir, carries an average stock price target met ratio of 50% that have a potential upside of 46% achieved within 114 days. Previously, Ahu Demir worked at LADENBURG, NOBLE CAPITAL.
Ahu Demir’s has documented 30 price targets and ratings displayed on 11 stocks. The coverage was on Healthcare, Basic Materials, Technology sectors.
Most recent stock forecast was given on EVAX, Evaxion Biotech AS at 02-Apr-2024.
Analyst best performing recommendations are on ONTX (ONCONOVA THERAPEUTICS).
The best stock recommendation documented was for ONTX (ONCONOVA THERAPEUTICS) at 12/22/2020. The price target of $6.9 was fulfilled within 1 day with a profit of $0.47 (7.31%) receiving and performance score of 73.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 31-Oct-2022
$16
3 years 8 months 25 days ago
(31-Oct-2022)
0/1 (0%)
$12 (300.00%)
Buy Since 07-Dec-2020
$0.55
$0.05 (10.00%)
3 years 9 months 6 days ago
(20-Oct-2022)
2/2 (100%)
$-0.13 (-19.12%)
50
Buy Since 21-Dec-2021
$18
3 years 11 months 10 days ago
(16-Aug-2022)
0/2 (0%)
$9.25 (105.71%)
Buy Since 10-Jun-2020
$6
4 years 3 months 26 days ago
(30-Mar-2022)
0/2 (0%)
$2.05 (51.90%)
Buy Since 21-Dec-2021
$12
$11.5 (2300.00%)
$18
4 years 3 months 26 days ago
(30-Mar-2022)
0/3 (0%)
$8 (200.00%)
What Year was the first public recommendation made by Ahu Demir?